Select your Country or Region

  • TargetMol | Compound LibraryArgentinaArgentina
  • TargetMol | Compound LibraryAustraliaAustralia
  • TargetMol | Compound LibraryAustriaAustria
  • TargetMol | Compound LibraryBelgiumBelgium
  • TargetMol | Compound LibraryBrazilBrazil
  • TargetMol | Compound LibraryBulgariaBulgaria
  • TargetMol | Compound LibraryCroatiaCroatia
  • TargetMol | Compound LibraryCyprusCyprus
  • TargetMol | Compound LibraryCzechCzech
  • TargetMol | Compound LibraryDenmarkDenmark
  • TargetMol | Compound LibraryEgyptEgypt
  • TargetMol | Compound LibraryEstoniaEstonia
  • TargetMol | Compound LibraryFinlandFinland
  • TargetMol | Compound LibraryFranceFrance
  • TargetMol | Compound LibraryGermanyGermany
  • TargetMol | Compound LibraryGreeceGreece
  • TargetMol | Compound LibraryHong KongHong Kong
  • TargetMol | Compound LibraryHungaryHungary
  • TargetMol | Compound LibraryIcelandIceland
  • TargetMol | Compound LibraryIndiaIndia
  • TargetMol | Compound LibraryIrelandIreland
  • TargetMol | Compound LibraryIsraelIsrael
  • TargetMol | Compound LibraryItalyItaly
  • TargetMol | Compound LibraryJapanJapan
  • TargetMol | Compound LibraryKoreaKorea
  • TargetMol | Compound LibraryLatviaLatvia
  • TargetMol | Compound LibraryLebanonLebanon
  • TargetMol | Compound LibraryMalaysiaMalaysia
  • TargetMol | Compound LibraryMaltaMalta
  • TargetMol | Compound LibraryMoroccoMorocco
  • TargetMol | Compound LibraryNetherlandsNetherlands
  • TargetMol | Compound LibraryNew ZealandNew Zealand
  • TargetMol | Compound LibraryNorwayNorway
  • TargetMol | Compound LibraryPolandPoland
  • TargetMol | Compound LibraryPortugalPortugal
  • TargetMol | Compound LibraryRomaniaRomania
  • TargetMol | Compound LibrarySingaporeSingapore
  • TargetMol | Compound LibrarySlovakiaSlovakia
  • TargetMol | Compound LibrarySloveniaSlovenia
  • TargetMol | Compound LibrarySpainSpain
  • TargetMol | Compound LibrarySwedenSweden
  • TargetMol | Compound LibrarySwitzerlandSwitzerland
  • TargetMol | Compound LibraryTaiwan,ChinaTaiwan,China
  • TargetMol | Compound LibraryThailandThailand
  • TargetMol | Compound LibraryTurkeyTurkey
  • TargetMol | Compound LibraryUnited KingdomUnited Kingdom
  • TargetMol | Compound LibraryUnited StatesUnited States
  • TargetMol | Compound LibraryOther CountriesOther Countries
Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Others
    (1)
Filter
Search Result
Results for "

neu 1

" in TargetMol Product Catalog
  • Recombinant Protein
    20
    TargetMol | Activity
  • Inhibitor Products
    9
    TargetMol | inventory
  • Peptides Products
    8
    TargetMol | natural
ELAAWCRWGFLLALLPPGIAG TFA
T82484
ELAAWCRWGFLLALLPPGIAG TFA (P5), a 21-amino-acid peptide (aa 5-25) originating from the rat HER2/neu protein, has been shown to elicit cytotoxic T lymphocyte (CTL) responses in mice with HER2-positive tumors [1].
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
SPPHPSPAFSPAFDNLYYWDQ TFA
T81111
SPPHPSPAFSPAFDNLYYWDQ TFA is a multi-epitope, class II rat HER2/neu peptide designed for research on the class II HER2-DC1 vaccine [1].
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
IRGRILHDGAYSLTLQGLGIH TFA
T82047
IRGRILHDGAYSLTLQGLGIH TFA, a multi-epitope class II rat HER2/neu peptide, is utilized in the study of class II HER2-DC1 vaccines [1].
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
SPPHPSPAFSPAFDNLYYWDQ
T811121443436-80-3
SPPHPSPAFSPAFDNLYYWDQ is a multi-epitope class II rat HER2/neu peptide applicable in the investigation of class II HER2-DC1 vaccine studies [1].
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
IRGRILHDGAYSLTLQGLGIH
T820481443436-79-0
IRGRILHDGAYSLTLQGLGIH is a multi-epitope class II rat HER2/neu peptide utilized in research for the class II HER2-DC1 vaccine studies [1].
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
ELAAWCRWGFLLALLPPGIAG
T824851443436-78-9
ELAAWCRWGFLLALLPPGIAG (P5), a 21-amino acid peptide (aa 5-25) derivative of the rat HER2/neu protein, has been shown to elicit cytotoxic T lymphocyte (CTL) responses in mice with HER2-positive tumors [1].
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
TYVPANASL TFA
T80906
TYVPANASL TFA, a nine-amino-acid MHC I-binding CD8 T-cell epitope derived from HER2/neu, is utilized in the formulation of J-LEAPS vaccines [1].
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
TYVPANASL
T80907921621-38-7
TYVPANASL, a nine-amino-acid MHC I-binding epitope from HER2/neu for CD8 T cells, can be utilized in the development of J-LEAPS vaccines [1].
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale